Stay updated on Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial
Sign up to get notified when there's something new on the Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial page.

Latest updates to the Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial page
- Check5 days agoChange DetectedA new revision entry (v3.6.3) was added to the record history, and the previous revision (v3.6.2) was removed. This reflects an update to the page's version history.SummaryDifference0.1%

- Check13 days agoChange DetectedA new revision entry v3.6.2 was added to the study record history. The previous v3.6.0 entry was removed, updating the record's version history.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe study record now shows 'No longer looking for participants', indicating enrollment for the trial is closed. The page revision tag was updated from v3.5.5 to v3.6.0, reflecting an updated version of the record.SummaryDifference0.4%

- Check34 days agoChange DetectedA new revision entry, v3.5.5, has been added to the Record History, replacing the previous v3.5.4. This indicates an update to the page's metadata or release notes on ClinicalTrials.gov.SummaryDifference0.1%

- Check55 days agoChange DetectedThe study record now shows 'Active, not recruiting' instead of 'Recruiting' and adds new sections for Study Status, Recruitment Status, and Contacts/Locations. The page also includes a new last update date (2026-05-11) and revision (v3.5.4).SummaryDifference0.9%

- Check77 days agoChange DetectedThe page’s interface revision/version label was updated from v3.5.2 to v3.5.3, indicating an internal site release without changing the study history details shown.SummaryDifference0.1%

Stay in the know with updates to Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial page.